mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months.
作者信息
Tande Aaron J, Pollock Benjamin D, Shah Nilay D, Binnicker Matthew, Berbari Elie F
机构信息
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Department of Quality, Experience, and Affordability, Mayo Clinic, Rochester, Minnesota.
出版信息
Infect Control Hosp Epidemiol. 2022 Mar;43(3):393-395. doi: 10.1017/ice.2021.399. Epub 2021 Sep 6.
Abstract
摘要
相似文献
1
mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months.七个月内mRNA疫苗对无症状严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的有效性
Infect Control Hosp Epidemiol. 2022 Mar;43(3):393-395. doi: 10.1017/ice.2021.399. Epub 2021 Sep 6.
2
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）mRNA 疫苗突破性感染表型包括明显症状、活病毒排出和病毒遗传多样性。
Clin Infect Dis. 2022 Mar 9;74(5):897-900. doi: 10.1093/cid/ciab543.
3
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
4
Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.2019冠状病毒病（COVID-19）mRNA疫苗对无症状医护人员的有效性
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1517-1519. doi: 10.1017/ice.2021.287. Epub 2021 Jun 24.
5
Strong Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Response of Previously Infected Healthcare Workers Given 1 Dose of mRNA Vaccine.曾感染过新冠病毒的医护人员接种一剂mRNA疫苗后的强效严重急性呼吸综合征冠状病毒2（SARS-CoV-2）中和抗体反应
Clin Infect Dis. 2022 Mar 1;74(4):746. doi: 10.1093/cid/ciab573.
6
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
7
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
8
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.2019冠状病毒病mRNA疫苗接种后确诊的急性心肌炎
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
9
Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。
Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.
10
Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review.严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗接种后发生的Sweet综合征：一例报告及文献综述
J Dermatol. 2022 May;49(5):e175-e176. doi: 10.1111/1346-8138.16309. Epub 2022 Jan 17.
引用本文的文献
1
Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis.普遍无症状术前SARS-CoV-2聚合酶链反应筛查的成本效益：一项成本效用分析。
Clin Infect Dis. 2024 Jan 25;78(1):57-64. doi: 10.1093/cid/ciad463.
2
The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis.2019冠状病毒病（COVID-19）疫苗的长期有效性：一项系统文献综述与荟萃分析
Antimicrob Steward Healthc Epidemiol. 2022 Feb 14;2(1):e22. doi: 10.1017/ash.2021.261. eCollection 2022.
3
Estimate of undetected severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in acute-care hospital settings using an individual-based microsimulation model.利用基于个体的微观模拟模型估计急性护理医院环境中未被发现的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染。
Infect Control Hosp Epidemiol. 2023 Jun;44(6):898-907. doi: 10.1017/ice.2022.174. Epub 2022 Sep 1.
4
Finding the off-ramp: Rethinking severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preoperative screening.找到匝道：重新思考严重急性呼吸综合征冠状病毒2（SARS-CoV-2）术前筛查
Infect Control Hosp Epidemiol. 2022 Jul;43(7):918-919. doi: 10.1017/ice.2022.2. Epub 2022 Jan 6.
5
Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.重新审视 COVID-19 政策：接下来该怎么做的 10 项基于证据的建议。
BMC Public Health. 2021 Nov 13;21(1):2084. doi: 10.1186/s12889-021-12082-z.
Zotero 插件